...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Oct 26, 2023

AGM has been announced.

8
Aug 13, 2023 10:14AM
4
Aug 14, 2023 11:09AM
Share
New Message
Please login to post a reply